Astronics Valuation
Is ATRO undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ATRO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ATRO ($17.18) is trading below our estimate of fair value ($359.75)
Significantly Below Fair Value: ATRO is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ATRO?
Key metric: As ATRO is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is ATRO's PS Ratio? | |
|---|---|
| PS Ratio | 0.8x |
| Sales | US$782.18m |
| Market Cap | US$575.09m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | 16.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ATRO's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 7.5x | ||
RDW Redwire | 2.5x | 14.9% | US$774.5m |
BYRN Byrna Technologies | 5.9x | 22.4% | US$480.2m |
NPK National Presto Industries | 1.5x | n/a | US$535.7m |
EH EHang Holdings | 20.1x | 37.0% | US$991.7m |
ATRO Astronics | 0.8x | 5.8% | US$575.1m |
Price-To-Sales vs Peers: ATRO is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (7.5x).
Price to Sales Ratio vs Industry
How does ATRO's PS Ratio compare vs other companies in the US Aerospace & Defense Industry?
Price-To-Sales vs Industry: ATRO is good value based on its Price-To-Sales Ratio (0.8x) compared to the US Aerospace & Defense industry average (2.5x).
Price to Sales Ratio vs Fair Ratio
What is ATRO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.8x |
| Fair PS Ratio | 0.7x |
Price-To-Sales vs Fair Ratio: ATRO is expensive based on its Price-To-Sales Ratio (0.8x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$17.18 | US$24.00 +39.7% | 16.7% | US$28.00 | US$20.00 | n/a | 2 |
| Nov ’25 | US$17.71 | US$24.00 +35.5% | 16.7% | US$28.00 | US$20.00 | n/a | 2 |
| Oct ’25 | US$19.56 | US$25.00 +27.8% | 12.0% | US$28.00 | US$22.00 | n/a | 2 |
| Sep ’25 | US$22.42 | US$25.00 +11.5% | 12.0% | US$28.00 | US$22.00 | n/a | 2 |
| Aug ’25 | US$21.82 | US$24.00 +10.0% | 8.3% | US$26.00 | US$22.00 | n/a | 2 |
| Jul ’25 | US$19.69 | US$22.50 +14.3% | 15.6% | US$26.00 | US$19.00 | n/a | 2 |
| Jun ’25 | US$20.56 | US$22.50 +9.4% | 15.6% | US$26.00 | US$19.00 | n/a | 2 |
| May ’25 | US$17.03 | US$23.50 +38.0% | 10.6% | US$26.00 | US$21.00 | n/a | 2 |
| Apr ’25 | US$18.41 | US$23.50 +27.6% | 10.6% | US$26.00 | US$21.00 | n/a | 2 |
| Mar ’25 | US$19.11 | US$23.50 +23.0% | 10.6% | US$26.00 | US$21.00 | n/a | 2 |
| Feb ’25 | US$17.56 | US$20.50 +16.7% | 12.2% | US$23.00 | US$18.00 | n/a | 2 |
| Jan ’25 | US$17.42 | US$20.00 +14.8% | 15.0% | US$23.00 | US$17.00 | n/a | 2 |
| Dec ’24 | US$15.33 | US$20.33 +32.6% | 12.3% | US$23.00 | US$17.00 | n/a | 3 |
| Nov ’24 | US$15.27 | US$20.33 +33.2% | 12.3% | US$23.00 | US$17.00 | US$17.71 | 3 |
| Oct ’24 | US$15.86 | US$20.33 +28.2% | 12.3% | US$23.00 | US$17.00 | US$19.56 | 3 |
| Sep ’24 | US$17.60 | US$20.33 +15.5% | 12.3% | US$23.00 | US$17.00 | US$22.42 | 3 |
| Aug ’24 | US$21.53 | US$19.33 -10.2% | 8.8% | US$21.00 | US$17.00 | US$21.82 | 3 |
| Jul ’24 | US$19.86 | US$18.67 -6.0% | 14.1% | US$21.00 | US$15.00 | US$19.69 | 3 |
| Jun ’24 | US$15.97 | US$17.33 +8.5% | 11.9% | US$20.00 | US$15.00 | US$20.56 | 3 |
| May ’24 | US$14.96 | US$16.00 +7.0% | 13.5% | US$18.00 | US$13.00 | US$17.03 | 3 |
| Apr ’24 | US$13.36 | US$15.50 +16.0% | 16.1% | US$18.00 | US$13.00 | US$18.41 | 2 |
| Mar ’24 | US$15.20 | US$12.00 -21.1% | 33.3% | US$16.00 | US$8.00 | US$19.11 | 2 |
| Feb ’24 | US$14.79 | US$12.00 -18.9% | 33.3% | US$16.00 | US$8.00 | US$17.56 | 2 |
| Jan ’24 | US$10.30 | US$11.50 +11.7% | 39.1% | US$16.00 | US$7.00 | US$17.42 | 2 |
| Dec ’23 | US$8.67 | US$11.50 +32.6% | 39.1% | US$16.00 | US$7.00 | US$15.33 | 2 |
| Nov ’23 | US$9.56 | US$12.00 +25.5% | 33.3% | US$16.00 | US$8.00 | US$15.27 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.
Discover undervalued companies
V2X
US$1.9b
Provides critical mission solutions and support services to defense clients worldwide.
VVX
US$59.53
7D
-1.9%
1Y
38.1%
MRC Global
US$1.1b
Through its subsidiaries, distributes pipes, valves, fittings, and other infrastructure products and services in the United States, Canada, and internationally.
MRC
US$13.31
7D
-1.9%
1Y
24.6%
NFI Group
CA$1.8b
Manufactures and sells buses in North America, the United Kingdom, rest of Europe, and the Asia Pacific.
NFYE.F
CA$10.86
7D
-0.2%
1Y
7.1%